Patent Strategies and Competition Law in the Pharmaceutical Sector:Implications for Access to Medicines


Potentially anti-competitive practices, such as reverse payment agreements and strategic patenting, risk allowing pharmaceutical companies to block the entry of generic and innovative medicines, stifling competition and harming consumers. Such practices create particular challenges for developing countries. Policy coherence between the IP system and competition law must be strengthened in order to promote innovation and access to health technologies.

Divisions: College of Business and Social Sciences > Aston Law School
College of Business and Social Sciences > Aston Business School
Publication ISSN: 0142-0461
Last Modified: 08 Dec 2023 10:46
Date Deposited: 18 Jul 2018 12:55
Full Text Link: https://qmro.qm ... 123456789/13672
Related URLs: http://www.swee ... px?recordid=460 (Publisher URL)
PURE Output Type: Article
Published Date: 2016-05-16
Accepted Date: 2016-05-16
Authors: Matthews, Duncan
Gurgula, Olga



Version: Accepted Version

| Preview

Export / Share Citation


Additional statistics for this record